© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
853120 |
As an accredited 6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Ask researchers in medicinal chemistry about triazolopyridines and many will mention the power of the 6-bromo variant. 6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine stands out because of its structure: bromine at the six position opens the door to more options in chemical synthesis. Having spent years in a lab surrounded by rows of compounds, I’ve seen how much difference a single atom makes—especially in a hotly pursued scaffold like this. Where some analogs present limited spots for fine-tuning, this one welcomes late-stage functionalization and cross-coupling, making it a versatile option for those working in pharmaceutical research and high-value material development.
The backbone consists of a triazole ring fused to pyridine, which gives it both rigidity and electronic richness. That bromo group is not just for show; it’s an entry point for Suzuki, Buchwald-Hartwig, or other coupling techniques. In practice, this means access to a richer library of derivatives, crucial for medicinal chemists hunting for lead compounds or fine-tuning properties like solubility, metabolic stability, or receptor selectivity. Over years of project work, I’ve come to appreciate molecules that offer this much possibility—rarely does a scaffold play this well with both small-scale innovation and later-stage optimization.
Many compounds crowd the shelves, so why opt for this one? From talking with colleagues and sifting through published studies, the answer is clear: flexibility in modification and reliability in reactivity drive its popularity. For example, compared to unsubstituted triazolopyridine, the bromo-substituted version lets researchers introduce virtually any group they want, from aryls and alkyls to more exotic heterocycles. This makes hit-to-lead optimization less of a slog. The heterocyclic system can modulate key properties, acting as a hinge for both activity and selectivity in drug candidates. Teams advancing central nervous system drugs often look for such scaffolds to break into new chemical spaces while retaining desirable binding profiles.
Purity tends to be critical in research and development settings. Speaking from direct experience, a good supplier provides this compound at purity levels above 97%, often exceeding 98% as determined by HPLC or GC. White to off-white powders mean minimal contaminants—important for complex, sensitive synthetic routes. Molecular weight clocks in at just over 200 g/mol, which keeps it in reach for standard organic transformations and helps avoid some handling headaches of larger, cumbersome molecules. Melting points fall in a predictable, reproducible range, which makes storage and quality control much easier. Packing always reflects attention to user needs—moisture-proof containers and detailed analysis reports come standard for trusted sources.
Recently, my conversations with drug development teams have focused on the struggle to discover selective, non-toxic molecules for difficult targets. 6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine frequently surfaces during hit identification screens, thanks to its balance of aromaticity, hydrogen bond acceptors, and points for substitution. Scientists chasing kinase inhibitors or CNS-active molecules praise its adaptability. Data mining shows a growing number of published patents and journal articles citing this scaffold for new mechanism-of-action candidates.
In structure-based drug design, the triazolopyridine core brings planarity and polarity—perfect for pi-stacking and key binding interactions. I’ve watched colleagues use it to solve the “flat” molecule problem, pushing analogs into more efficient binding pockets. Substitution at the six position does much of the heavy lifting, introducing flexibility without losing intracellular activity.
Industrial chemists give attention to this scaffold not only for drug pipelines but also for advanced materials. Incorporating 6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine into ligands fuels a wide range of metal-organic frameworks, catalysts, and fluorescent probes. I remember working with a research group focused on luminescent dyes—the bromo group allowed us to link the core to larger fragments and fine-tune emission properties. The rigidity and electron-rich system helps create polymers with specific optoelectronic or conductive properties. Manufacturers interested in smart materials or next-generation sensors find it a solid starting point, thanks to ease of functionalization.
Structural analogs pop up all the time—some with chlorine or methyl groups in place of bromine, or even unsubstituted versions. Each brings unique reactivity. With a chlorine atom, reactivity drops and often demands harsher coupling conditions. Methyl variants deliver less versatility for further modifications, sealing off one avenue for late-stage tinkering. Compared to standard pyridines or simple triazoles, this compound’s fused system supports more rigid frameworks, limiting the conformational chaos that can frustrate SAR (structure-activity relationship) studies.
From my vantage point, synthetic success rates rise with the bromo compound because reaction conditions stay milder, reducing byproduct headaches and process failures. Teams striving for green chemistry goals have noted reduced need for hazardous reagents during cross-coupling—it represents a safer, more productive reagent all around. Synthetic yields trend higher, and purification steps become less of a bottleneck, which accelerates project timelines.
The reliability of 6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine hinges not just on the structure, but also on upstream processes. I’ve watched new suppliers cut corners only to wind up with batches tainted by hard-to-remove impurities, jeopardizing a full week of research. The best sources invest in rigorous chromatography and careful crystallization, confirmed by thorough NMR and mass spec checks. Outsourcing production to skilled chemists with years of heterocycle experience pays off in reduced material wastage and better reproducibility. The typical package also comes with a certificate backed by real analytical data—no fuzzy purity claims, just numbers and supporting graphs.
Storage matters, too. Stable room temperature storage in sealed vials keeps the product dry and safe. Some users go as far as to aliquot powder into smaller vials to dodge repeated exposure to air and moisture, prolonging shelf life and ensuring each transfer delivers what’s needed for the next synthetic campaign.
Shifting from theory to the fume hood, I’ve seen how manipulation calls for a firm grasp of coupling chemistry. The bromo group often means faster reactions under milder conditions. Whenever we needed to install an aryl group, Suzuki coupling proved the quickest route. Buchwald-Hartwig is another mainstay, unlocking amine derivatives that tap into rich medicinal chemistry space. No-compromise reactions yield better results, cleaner byproducts, and more confidence pushing into larger-scale runs.
If there’s one lesson the bench teaches, it’s the value of prep work. Protecting groups and solvent purity deserve close attention when bringing this molecule into synthesis. Chemists who rush the process often find themselves retracing steps due to side reactions or diminished yields. Frequent analytical checks confirm the stepwise integrity of intermediates, preventing costly project pivots.
Despite the advantages, every building block has quirks, and 6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine is no exception. Some researchers report solubility issues in aqueous mediums, demanding more organic solvent or specialized co-solvents. Others point out the tendency for the bromo group to undergo unwanted side reactions if not controlled—overheating or impure reagents can trigger rogue substitutions. Having run dozens of reactions myself, a patient approach wins the day: lower temperatures, slow reagent addition, and the right ligands all help keep the process on track.
Waste management is another aspect few mention, but which plays a central role in sustainable chemistry. Since bromine derivatives carry environmental burdens, responsible disposal and minimal excess use count for a lot. Teams embracing greener protocols often switch from large-scale batch runs to flow chemistry, minimizing exposures and cutting down on hazardous byproducts.
Chemical sourcing requires more than price comparisons. In today’s landscape, ethical supply chains matter. Reputable suppliers trace raw materials from responsible producers, committing to both quality and environmental stewardship. I’ve seen teams switch vendors after discovering dubious sourcing, only to improve overall project outcomes with cleaner, more reliable material. Certificates of analysis back up safety data sheets, but personal responsibility counts just as much—wearing the right PPE, following established handling protocols, and preparing for emergencies should factor into every purchase and use.
Brominated heterocycles warrant special handling, as inhalation or skin contact can present health hazards. Lab cultures that adopt careful training and up-to-date equipment see fewer accidents. For newcomers, experienced mentors pass down not just the protocols, but the respect for the materials themselves—any shortcut today could spell disaster tomorrow.
Several projects in both academic and industrial settings rely on this compound as the starting point for advances in therapy and technology. Drug discovery campaigns for inflammatory diseases have leveraged its core, achieving unexpected selectivity by using the bromo group to dial in optimal interactions at target sites. I’ve watched colleagues pair the scaffold with cutting-edge computational models, balancing physicochemical properties while chasing down previously “undruggable” targets.
Outside medicine, recent work in materials science highlighted its role in crafting new photoactive surfaces. One group used cross-coupling to build up a series of donor–acceptor systems, achieving precise bandgap engineering for solar cells. The bromo functionality enabled near-perfect control over molecular orientation and packing, leading to better device performance and commercial potential.
Other teams, focused on analytical chemistry, use derivatives of 6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine as chemosensors or as ligands in metal catalyst frameworks. Such systems have shown improved selectivity and response times, pinpointing analytes in complex mixtures that previous generations of sensors missed.
Interest in this heterocycle grows year after year, as researchers discover additional roles in diagnostics, target validation, and material development. Ongoing work explores dual-action drug candidates—where the triazolopyridine core enables both enzymatic inhibition and imaging capabilities with minimal additional modification. Other projects merge green chemistry advances with the robust reactivity of the bromo core, reducing the use of harmful solvents and energy-intensive conditions.
Teams investigating next-generation bioorthogonal “click” reactions have introduced more environmentally benign reagents, turning to this scaffold as a test bed for high-value transformations. Insights trickle down from big pharma into startup accelerators, giving rise to spinoff technology focused on highly specific catalysts or advanced electronic materials.
Sharing best practices and open-source syntheses remains vital to accelerating progress and reducing barriers to entry in emerging regions. Those who offer transparency in production and robust technical support get more than repeat customers—they build a reputation for quality and partnership in discovery.
Supply chain stability keeps top-of-mind with any high-value reagent. Chemists building robust supplier relationships and investing in multiple procurement routes weather shortages better. Product stewardship programs that take back spent containers or offer technical support can further reduce risk. In my experience, collaborative partnerships with suppliers—not transactional buying—lead to more consistent results, whether the project calls for grams or kilograms.
For solubility and handling issues, simple fixes like using fresh, dry solvents and working under inert atmospheres smooth out most workflow interruptions. Routine analytical checks, from melting point determination to LC-MS scans, offer an early warning system for purity drift or cross-contamination—adopting these habits keeps batch-to-batch reproducibility high. Continuous dialogue with technical teams, both inside and outside the organization, brings solutions to any persistent synthetic bottleneck.
Institutions and individual labs can further support sustainability goals by focusing on high-yield routes and efficient purification strategies, cutting down on chemical waste and lowering the environmental footprint of their research. Training new generations of chemists in both classic and trending synthesis techniques ensures that know-how passes seamlessly, reducing costly mistakes and paving the way for future innovation.
6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine earns its place in the toolkit by offering both flexibility and reliability across many scientific disciplines. Through trial, error, and collaboration, chemists have unlocked new uses for this building block, driving advances in drug discovery, advanced materials, and sustainable chemistry. The molecule’s future looks as robust as its track record; teams embracing its unique reactivity and pushing the boundaries of what’s possible will continue finding new horizons in their research.
